Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Gross margin
€ -869,288
▼ 11992% vs 2024
Profit
Caution€ -2.1 million
▼ 98% vs 2024
Debts
Low€ 913,069
▼ 37% vs 2024
THERAtRAME from Liège, company number BE0786448581, closed financial year 2025 with a result of € -2.1 million after tax. For that financial year THERAtRAME recorded a gross margin of € -869,288 and equity of € 1.8 million. Compared with financial year 2024, the result moved from € -1.1 million to € -2.1 million. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.
What happened at THERAtRAME?
What happened at THERAtRAME in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Jérôme Majoie stepped down as director. NBB
- JCO Consulting SRL stepped down as director. NBB
- QBIC VENTURE PARTNERS III SA stepped down as director. NBB
- NOSHAQ PARTNERS SRL stepped down as director. NBB
- R&D Close SRL stepped down as director. NBB
- RAPINO Management SRL stepped down as director. NBB
- Didier ALLAER stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 2.1 million. Source: NBB ↗
In short
From € 1.1 million loss in 2023 to € 2.1 million loss in 2025.
On average € 1,000 of value added per employee in 2024.
A new publication or filing at THERAtRAME? We notify you, reason included.
Follow THERAtRAMENeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Director · represented by LIMBOURG Marleen
Also active at: CAUTION MUTUELLE DES METIERS ET NEGOCES, Fonderies J. Marichal Ketin et Cie, DARDENNE +174 more
since 2022 · until 2028
since 2022 · until 2025
Director · represented by Combalbert Jean
Also active at: Newton Biocapital I, pricaf privée de droit belge, EPICS THERAPEUTICS
since 2025 · until 2031
Managing director · represented by CLOSE Pierre
since 2022 · until 2028
Managing director · represented by RAPINO Francesca
since 2022 · until 2028
Director · represented by MATTIVI Didier
Also active at: MICROBELCAPS, NOSHAQ SPIN-OFFS, PRESSES UNIVERSITAIRES DE LIEGE +16 more
since 2022 · until 2026
since 2022 · until 2028
Director · represented by VANDENWIJNGAERT Sara
Also active at: RheaVita, VoxelSensors, AnimAb +7 more
since 2023 · until 2029
Jérôme Majoie
Director
since 2026 · until 2032
Establishments
Establishment units
Physical locations of this company
Avenue de l'Hôpital 1
4000 Liège
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 11 companies are registered at this address.
Centre hospitalier universitaire de Liège
Bureau International d'Audiophonologie
CENTRE ANTICANCEREUX PRES L'UNIVERSITE DE LIEGE
Inokura
€ 6.4 million revenue · 2025
Belgian Bone Club
+6 more
Details
- Company number
- 0786.448.581
- VAT number
- BE 0786.448.581
- Registered office
- Avenue de l'Hôpital 1, 4000 Liège
- Names & denominations
- THERAtRAME
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 23 May 2022
- Peppol
- Active · Active since 17 Dec 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Speur- en ontwikkelingswerk op het gebied van de maatschappij- en geesteswetenschappen
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied